Tender Offer Commences for BioClinica

BioClinica and JLL Partners have announced that BC Acquisition Corp has commenced a tender offer for all outstanding shares of BioClinica at a price of $7.25 per share net to the seller in cash. BioClinica is a provider of clinical trial management solutions.

DealsNorth AmericaUSBriefs